These guidelines state that for women presenting with suspected preeclampsia at <35 weeks of gestation (base case), total costs were £6,456 when using the Elecsys sFlt-1/PlGF ratio test, compared with £8,945 for the standard of care, yielding cost savings of £2,488 per patient. This evidence concerns the gene PGF and preeclampsia.